Librería: RUSH HOUR BUSINESS, Worcester, MA, Estados Unidos de America
EUR 70,99
Cantidad disponible: 1 disponibles
Añadir al carritohardcover. Condición: Very Good. Pages are clean with no markings.
Librería: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 139,30
Cantidad disponible: 8 disponibles
Añadir al carritoCondición: new.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 152,42
Cantidad disponible: 8 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
EUR 154,32
Cantidad disponible: 8 disponibles
Añadir al carritoCondición: New.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 148,24
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 148,23
Cantidad disponible: 8 disponibles
Añadir al carritoCondición: New.
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
EUR 152,09
Cantidad disponible: 8 disponibles
Añadir al carritoCondición: As New. Unread book in perfect condition.
Idioma: Inglés
Publicado por John Wiley and Sons Inc, US, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Librería: Rarewaves.com USA, London, LONDO, Reino Unido
EUR 179,81
Cantidad disponible: 4 disponibles
Añadir al carritoHardback. Condición: New. This book helps readers integrate in silico, in vitro, and in vivo ADMET (absorption, distribution, metabolism, elimination and toxicity) and PK (pharmacokinetics) data with routine testing applications so that pharmaceutical scientists can diagnose ADMET problems and present appropriate recommendations to move drug discovery programs forward. The book introduces the current clinical practice for drug discovery and development along with the impact on early risk assessment; consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET data; and demonstrates successful cases and lessons learned from real drug discovery and development. In short, it is a book aimed to provide a practical road map for drug discovery and development scientists to generate efficacious and safe drugs for unmet medical needs.
EUR 173,35
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New. pp. 336.
Librería: Chiron Media, Wallingford, Reino Unido
EUR 169,07
Cantidad disponible: 8 disponibles
Añadir al carritoHardcover. Condición: New.
EUR 184,22
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New. pp. 616.
EUR 164,05
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
EUR 189,22
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New. pp. 336.
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
EUR 169,05
Cantidad disponible: 8 disponibles
Añadir al carritoHardback. Condición: New. New copy - Usually dispatched within 4 working days.
EUR 188,58
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. By guiding in the application of techniques and tools for predicting ADMET outcomes in drug candidates, Predictive ADMET offers a road map for drug discovery scientists to generate effective and safe drugs for unmet medical needs. Num Pages: 616 pages, illustrations. BIC Classification: MMG; PN; TDCW. Category: (P) Professional & Vocational. Dimension: 241 x 156 x 39. Weight in Grams: 996. . 2014. Hardback. . . . .
EUR 205,35
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New. pp. 616.
EUR 161,05
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. Jianling Wang is the Cambridge Head of Discovery ADME at Novartis Institutes for BioMedical Research. He has published over 40 journal papers, reviews, and book chapters and lectured at over 30 scientific conferences and courses. Laszlo Urban is the Executi.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 219,08
Cantidad disponible: 2 disponibles
Añadir al carritoHardcover. Condición: Brand New. 596 pages. 9.50x6.50x1.50 inches. In Stock.
EUR 236,74
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. By guiding in the application of techniques and tools for predicting ADMET outcomes in drug candidates, Predictive ADMET offers a road map for drug discovery scientists to generate effective and safe drugs for unmet medical needs. Num Pages: 616 pages, illustrations. BIC Classification: MMG; PN; TDCW. Category: (P) Professional & Vocational. Dimension: 241 x 156 x 39. Weight in Grams: 996. . 2014. Hardback. . . . . Books ship from the US and Ireland.
Idioma: Inglés
Publicado por John Wiley and Sons Inc, US, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Librería: Rarewaves.com UK, London, Reino Unido
EUR 169,88
Cantidad disponible: 4 disponibles
Añadir al carritoHardback. Condición: New. This book helps readers integrate in silico, in vitro, and in vivo ADMET (absorption, distribution, metabolism, elimination and toxicity) and PK (pharmacokinetics) data with routine testing applications so that pharmaceutical scientists can diagnose ADMET problems and present appropriate recommendations to move drug discovery programs forward. The book introduces the current clinical practice for drug discovery and development along with the impact on early risk assessment; consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET data; and demonstrates successful cases and lessons learned from real drug discovery and development. In short, it is a book aimed to provide a practical road map for drug discovery and development scientists to generate efficacious and safe drugs for unmet medical needs.
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 200,66
Cantidad disponible: 2 disponibles
Añadir al carritoBuch. Condición: Neu. Neuware - This book helps readers integrate in silico, in vitro, and in vivo ADMET (absorption, distribution, metabolism, elimination and toxicity) and PK (pharmacokinetics) data with routine testing applications so that pharmaceutical scientists can diagnose ADMET problems and present appropriate recommendations to move drug discovery programs forward.The book introduces the current clinical practice for drug discovery and development along with the impact on early risk assessment; consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET data; and demonstrates successful cases and lessons learned from real drug discovery and development. In short, it is a book aimed to provide a practical road map for drug discovery and development scientists to generate efficacious and safe drugs for unmet medical needs.
Idioma: Inglés
Publicado por John Wiley & Sons Inc, New York, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de America
Original o primera edición Impresión bajo demanda
EUR 173,40
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: new. Hardcover. This book helps readers integrate in silico, in vitro, and in vivo ADMET (absorption, distribution, metabolism, elimination and toxicity) and PK (pharmacokinetics) data with routine testing applications so that pharmaceutical scientists can diagnose ADMET problems and present appropriate recommendations to move drug discovery programs forward. The book introduces the current clinical practice for drug discovery and development along with the impact on early risk assessment; consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET data; and demonstrates successful cases and lessons learned from real drug discovery and development. In short, it is a book aimed to provide a practical road map for drug discovery and development scientists to generate efficacious and safe drugs for unmet medical needs. By guiding in the application of techniques and tools for predicting ADMET outcomes in drug candidates, Predictive ADMET offers a road map for drug discovery scientists to generate effective and safe drugs for unmet medical needs. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
EUR 176,04
Cantidad disponible: Más de 20 disponibles
Añadir al carritoHardback. Condición: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days 1029.
Idioma: Inglés
Publicado por John Wiley & Sons Inc, New York, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Librería: CitiRetail, Stevenage, Reino Unido
Original o primera edición Impresión bajo demanda
EUR 159,87
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: new. Hardcover. This book helps readers integrate in silico, in vitro, and in vivo ADMET (absorption, distribution, metabolism, elimination and toxicity) and PK (pharmacokinetics) data with routine testing applications so that pharmaceutical scientists can diagnose ADMET problems and present appropriate recommendations to move drug discovery programs forward. The book introduces the current clinical practice for drug discovery and development along with the impact on early risk assessment; consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET data; and demonstrates successful cases and lessons learned from real drug discovery and development. In short, it is a book aimed to provide a practical road map for drug discovery and development scientists to generate efficacious and safe drugs for unmet medical needs. By guiding in the application of techniques and tools for predicting ADMET outcomes in drug candidates, Predictive ADMET offers a road map for drug discovery scientists to generate effective and safe drugs for unmet medical needs. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Librería: Revaluation Books, Exeter, Reino Unido
EUR 199,17
Cantidad disponible: 2 disponibles
Añadir al carritoHardcover. Condición: Brand New. 596 pages. 9.50x6.50x1.50 inches. In Stock. This item is printed on demand.
Idioma: Inglés
Publicado por John Wiley & Sons Inc, New York, 2014
ISBN 10: 1118299922 ISBN 13: 9781118299920
Librería: AussieBookSeller, Truganina, VIC, Australia
Original o primera edición Impresión bajo demanda
EUR 233,75
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: new. Hardcover. This book helps readers integrate in silico, in vitro, and in vivo ADMET (absorption, distribution, metabolism, elimination and toxicity) and PK (pharmacokinetics) data with routine testing applications so that pharmaceutical scientists can diagnose ADMET problems and present appropriate recommendations to move drug discovery programs forward. The book introduces the current clinical practice for drug discovery and development along with the impact on early risk assessment; consolidates the tools and models to intelligently integrate existing in silico, in vitro and in vivo ADMET data; and demonstrates successful cases and lessons learned from real drug discovery and development. In short, it is a book aimed to provide a practical road map for drug discovery and development scientists to generate efficacious and safe drugs for unmet medical needs. By guiding in the application of techniques and tools for predicting ADMET outcomes in drug candidates, Predictive ADMET offers a road map for drug discovery scientists to generate effective and safe drugs for unmet medical needs. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.